ANTI-ANGIOGENIC THERAPY IN CANCER TREATMENT AS AN OPTIMAL CONTROL PROBLEM
暂无分享,去创建一个
[1] H. Schättler,et al. A Synthesis of Optimal Controls for a Model of Tumor Growth under Angiogenic Inhibitors , 2005, Proceedings of the 44th IEEE Conference on Decision and Control.
[2] Yuri Kogan,et al. Critical-point analysis for three-variable cancer angiogenesis models. , 2005, Mathematical biosciences and engineering : MBE.
[3] J. Goldie. Drug Resistance in Cancer: A Perspective , 2004, Cancer and Metastasis Reviews.
[4] Lamberto Cesari,et al. Optimization-Theory And Applications , 1983 .
[5] Heinz Schättler,et al. A synthesis of time-optimal controls in the presence of saturated singular arcs , 1993 .
[6] L. Loeb,et al. A mutator phenotype in cancer. , 2001, Cancer research.
[7] M. L. Chambers. The Mathematical Theory of Optimal Processes , 1965 .
[8] L. Wein,et al. Optimal scheduling of radiotherapy and angiogenic inhibitors , 2003, Bulletin of mathematical biology.
[9] A. Krener. The High Order Maximal Principle and Its Application to Singular Extremals , 1977 .
[10] Application of Optimal Control to a System Describing Tumor Anti-Angiogenesis , 2006 .
[11] U. Ledzewicz. Optimal Control for a System Modelling Tumor Anti-Angiogenesis , 2006 .
[12] B. Bonnard,et al. Toward a Geometric Theory in the Time-Minimal Control of Chemical Batch Reactors , 1995 .
[13] Peteris Daugulis,et al. Hopf point analysis for angiogenesis models , 2003 .
[14] P. Hahnfeldt,et al. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.
[15] Alberto Gandolfi,et al. Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999). , 2004, Mathematical biosciences.
[16] R. Kerbel. A cancer therapy resistant to resistance , 1997, Nature.